Identification of suitable reference genes for the relative quantification of microRNAs in pleural effusion

Oncology Letters

Volumn 8, Issue 4, 2014, Pages 1889-1895

  Han, Hye Suk ^a   Jo, Yeong Nang ^b   Lee, Jin Yong ^c   Choi, Song Yi ^a   Jeong, Yusook ^a   Yun, Jieun ^b   Lee, Ok Jun ^a  

^a Chungbuk National University College of Medicine   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c Seoul National University Boramae Hospital   (South Korea)

Author keywords

microRNAs; Pleural effusion; Reference

Indexed keywords

MICRORNA; MICRORNA 16; MICRORNA 192; MICRORNA 198; MICRORNA 20A; MICRORNA 221; MICRORNA 222; SMALL NUCLEAR RNA; SMALL NUCLEOLAR RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE IDENTIFICATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT PLEURA EFFUSION; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PLEURA EFFUSION; POLYMERASE CHAIN REACTION; QUANTITATIVE POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; VALIDATION PROCESS;

EID: 84939814378     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2404     Document Type: Article

References (32)

1. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
2. Cho WC: MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int J Biochem Cell Biol 42: 1273-1281, 2010.
3. Zhou L, Zhao YP, Liu WJ, et al: Circulating microRNAs in cancer: diagnostic and prognostic significance. Expert Rev Anticancer Ther 12: 283-288, 2012.
4. Cortez MA, Bueso-Ramos C, Ferdin J, et al: MicroRNAs in body fluids-the mix of hormones and biomarkers. Nat Rev Clin Oncol 8: 467-477, 2011.
5. Tsim S, O'Dowd CA, Milroy R and Davidson S: Staging of non-small cell lung cancer (NSCLC): a review. Respir Med 104: 1767-1774, 2010.
6. Nance KV, Shermer RW and Askin FB: Diagnostic efficacy of pleural biopsy as compared with that of pleural fluid examination. Mod Pathol 4: 320-324, 1991.
7. Xie L, Chen X, Wang L, et al: Cell-free miRNAs may indicate diagnosis and docetaxel sensitivity of tumor cells in malignant effusions. BMC Cancer 10: 591, 2010.
8. Xie L, Wang T, Yu S, et al: Cell-free miR-24 and miR-30d, potential diagnostic biomarkers in malignant effusions. Clin Biochem 44: 216-220, 2011.
9. Han HS, Yun J, Lim SN, et al: Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion. Int J Cancer 133: 645-652, 2013.
10. Mestdagh P, Van Vlierberghe P, De Weer A, et al: A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol 10: R64, 2009.
11. Ratert N, Meyer HA, Jung M, et al: Reference miRNAs for miRNAome analysis of urothelial carcinomas. PLoS One 7: e39309, 2012.
12. Song J, Bai Z, Han W, et al: Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients. Dig Dis Sci 57: 897-904, 2012.
13. Wotschofsky Z, Meyer HA, Jung M, et al: Reference genes for the relative quantification of microRNAs in renal cell carcinomas and their metastases. Anal Biochem 417: 233-241, 2011.
14. Chang KH, Mestdagh P, Vandesompele J, Kerin MJ and Miller N: MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer. BMC Cancer 10: 173, 2010.
15. Gee HE, Buffa FM, Camps C, et al: The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis. Br J Cancer 104: 1168-1177, 2011.
16. Wang T, Lv M, Shen S, et al: Cell-free microRNA expression profiles in malignant effusion associated with patient survival in non-small cell lung cancer. PLoS One 7: e43268, 2012.
17. Andersen CL, Jensen JL and Ørntoft TF: Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64: 5245-5250, 2004.
18. Pfaffl MW, Tichopad A, Prgomet C and Neuvians TP: Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper-Excel-based tool using pair-wise correlations. Biotechnol Lett 26: 509-515, 2004.
19. Song B, Wang Y, Kudo K, et al: miR-192 Regulates Dihydrofolate Reductase and Cellular Proliferation through the p53-microRNA Circuit. Clin Cancer Res 14: 8080-8086, 2008.
20. Wu H, Wang F, Hu S, et al: MiR-20a and miR-106b negatively regulate autophagy induced by leucine deprivation via suppression of ULK1 expression in C2C12 myoblasts. Cell Signal 24: 2179-2186, 2012.
21. Visone R, Russo L, Pallante P, et al: MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocr Relat Cancer 14: 791-798, 2007.
22. Cimmino A, Calin GA, Fabbri M, et al: miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102: 13944-13949, 2005.
23. Kiss T: Small nucleolar RNA-guided post-transcriptional modification of cellular RNAs. EMBO J 20: 3617-3622, 2001.
24. Dieci G, Preti M and Montanini B: Eukaryotic snoRNAs: a paradigm for gene expression flexibility. Genomics 94: 83-88, 2009.
25. Galardi S, Fatica A, Bachi A, et al: Purified box C/D snoRNPs are able to reproduce site-specific 2'-O-methylation of target RNA in vitro. Mol Cell Biol 22: 6663-6668, 2002.
26. Peltier HJ and Latham GJ: Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 14: 844-852, 2008.
27. Chen X, Ba Y, Ma L, et al: Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006, 2008.
28. Git A, Dvinge H, Salmon-Divon M, et al: Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression. RNA 16: 991-1006, 2010.
29. Dong XY, Guo P, Boyd J, et al: Implication of snoRNA U50 in human breast cancer. J Genet Genomics 36: 447-454, 2009.
30. Mourtada-Maarabouni M, Pickard MR, Hedge VL, Farzaneh F and Williams GT: GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene 28: 195-208, 2009.
31. Kroh EM, Parkin RK, Mitchell PS and Tewari M: Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50: 298-301, 2010.
32. Tricarico C, Pinzani P, Bianchi S, et al: Quantitative real-time reverse transcription polymerase chain reaction: normalization to rRNA or single housekeeping genes is inappropriate for human tissue biopsies. Anal Biochem 309: 293-300, 2002.